- Arcimoto Inc (NASDAQ:FUV) has received $6 million in additional funding by means of a real estate loan on their Eugene, Oregon factory.
- The additional financing comes shortly after the $12 million public offering closed on Jan. 20, 2023.
- The company used a portion of the net proceeds to repay the convertible note with 3i. The remaining funding will be used for working capital and general corporate purposes.
- Also Read: Arcimoto Registers 20% Sequential Growth In Q4 Deliveries
- “This additional funding paired with our efforts in reducing vehicle costs and increasing sales gives the team practical confidence as we continue to focus on the growth of FUV and Deliverator programs,” said Jesse Fittipaldi, Arcimoto Interim CEO.
- Price Action: FUV shares are trading lower by 1.61% at $1.83 on the last check Wednesday.
AstraZeneca Announced Lynparza Approved in China for Ovarian Cancer
AstraZeneca and MSD's Lynparza (olaparib) has been approved in China for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to 1st-line platinum-based chemotherapy in combination with bevacizumab, and whose cancer is associated with homologous recombination deficiency (HRD)-positive statu
